People · Operator
Named in public records as an officer, director or promoter · active 2015–2015 · Biotechnology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cleveland Diagnostics, Inc. | — | Biotechnology | Series C | $73.3M | $79.4M | 2015 |
| Centerline Biomedical, Inc. | — | Biotechnology | Series B | $71.8M | $55.1M | 2015 |
| Cardionomic, Inc. | — | Other Health Care | Series B | $51.7M | $76.3M | 2015 |
Karen Shanahan at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Karen Shanahan on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Akhil Saklecha | 2 | 3 |
| Ali Behbahani | 1 | 17 |
| Tara Butler | 1 | 12 |
| Brian Farley | 1 | 5 |
| Michael DeMane | 1 | 4 |
| Ben Bronstein | 1 | 4 |
| Jeffrey Marshall | 1 | 3 |
| ANDREW SUMMERS | 1 | 3 |
| JOSEPH RICH | 1 | 2 |
| William Abraham | 1 | 2 |
| Jay Graf | 1 | 2 |
| NOEL JEE | 1 | 2 |
| Arnon Chait | 1 | 2 |
| SAMEER ROHATGI | 1 | 2 |
| Jai N. Gupta | 1 | 2 |
| Michael Whitman | 1 | 2 |
| Vikash N. Goel | 1 | 1 |
| Jim Zalar | 1 | 1 |
| Jim N. Zalar | 1 | 1 |
| Tony Borowicz | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.